Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
AX Coin under Huaying Group partners with Fireblocks to empower the next generation of digital currencies

AX Coin under Huaying Group partners with Fireblocks to empower the next generation of digital currencies

格隆汇格隆汇2026/06/05 08:32
Show original
```htmlGelonghui June 5th|AX Coin, a Stablecoin issuer under Huaying Group (Nasdaq: AXG) licensed and regulated by the Central Bank of Bahrain, officially announced its partnership with Fireblocks today. Fireblocks is a global leader in digital asset infrastructure, having secured over $14 trillion in digital asset transfers. This collaboration aims to empower the next generation of institutional-grade Stablecoins. Fireblocks is trusted by more than 2,400 financial institutions, payment providers, exchanges, custodians, and Stablecoin issuers worldwide, providing the scale, security, and resilience required for modern digital finance. By leveraging Fireblocks' MPC-based wallet architecture, private key management technology, and connectivity across more than 150 blockchains, AX Coin is building a secure and scalable platform designed for institutional payments, cross-border settlements, and global-scale digital asset circulation. Fireblocks' proven infrastructure will support AX Coin in realizing its mission to establish a globally interconnected Stablecoin ecosystem.```
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage